John Despain is a Dermatology physician. OpenAlex indexes 13 publications with 347 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5721 Osage Beach Pkwy Ste 100
Osage Beach, MO 650653030
Telephone
573-302-4696Provider last certified this registry record 14 Aug 2024.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202528 payments$28,646openpaymentsdata.cms.gov ↗
- Janssen Biotech, Inc.Program year20256 payments
- ABBVIE INC.Program year202512 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
39.6%Azole Antifungal16.4%Ketoconazole92%Fluconazole8%Part D≥117 patientsTetracycline-class Drug12.6%Doxycycline Hyclate59%Minocycline Hcl41%Part D≥69 patients+ 4 more classes in this area
Dermatology
21.6%Corticosteroid14.5%Triamcinolone Acetonide83%Triamcinolone acetonide11%Fluocinolone Acetonide6%Part D + Part B<11 patientsalpha-Hydroxy Acid3.6%Ammonium Lactate100%Part D≥27 patients+ 3 more classes in this area
Cardiovascular
9.8%Blood Viscosity Reducer3.1%Pentoxifylline100%Part D≥13 patientsCorticosteroid2.9%Fluocinonide100%Part D≥28 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical inquiries. What is the best oral antifungal medication for tinea capitis?
PubMed
2001 - Common Benign Cutaneous Tumors And Tumor-Like Lesions Of The Head And Neck
Otolaryngologic Clinics of North America
1993 - Clinical, Histologic, and Immunofluorescent Distinctions Between Subacute Cutaneous Lupus Erythematosus and Discoid Lupus Erythematosus
Journal of Investigative Dermatology
1992 - Dermatologic toxicity of chemotherapy.
PubMed
1992
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”